Key Developments: Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

81.55USD
10:59am EST
Price Change (% chg)

$0.03 (+0.04%)
Prev Close
$81.52
Open
$81.65
Day's High
$81.80
Day's Low
$81.35
Volume
804,805
Avg. Vol
3,695,932
52-wk High
$81.80
52-wk Low
$64.64

Search Stocks

Latest Key Developments (Source: Significant Developments)

Express Scripts Holding Co narrows FY 2014 EPS guidance to a range in line with analysts' estimates; gives Q4 2014 EPS guidance in line with analysts' estimates
Tuesday, 28 Oct 2014 04:01pm EDT 

Express Scripts Holding Co:Narrows FY 2014 adjusted earnings per diluted share guidance from a range of $4.84 to $4.92 to a range of $4.86 to $4.90, which maintains the mid-point of $4.88.Expects Q4 2014 Adjusted earnings per diluted share in the range of $1.36 to $1.40.FY 2014 EPS of $4.88 - Thomson Reuters I/B/E/S.Q4 2014 EPS of $1.38 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co collaborates with Walgreens to create value-driven medicare prescription drug plan pharmacy network
Wednesday, 1 Oct 2014 07:30am EDT 

Express Scripts Holding Co:Says that its two nationally available 2015 Express Scripts Medicare Prescription Drug Plans (PDP) will offer a preferred retail pharmacy network featuring Walgreens, helping America's seniors obtain more value, choice and clinical support for their Medicare dollars.  Full Article

Express Scripts Holding Co narrows FY 2014 EPS guidance to a range in line with analysts' estimates; gives Q3 2014 EPS guidance in line with analysts' estimates
Tuesday, 29 Jul 2014 04:25pm EDT 

Express Scripts Holding Co:Narrows adjusted earnings per diluted share (EPS) guidance from range of $4.82 to $4.94 to range of $4.84 to $4.92, which maintains mid-point of $4.88.Expects Q3 3014 adjusted earnings per diluted share in the range of $1.27 to $1.31.FY 2014 EPS of $4.86 and Q3 2014 EPS of $1.28 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co gives Q2 2014 EPS guidance below analysts' estimates; lowers FY 2014 earnings guidance
Tuesday, 29 Apr 2014 04:02pm EDT 

Express Scripts Holding Co:Expects Q2 2014 adjusted earnings per share of $1.20 to $1.24.Expects FY 2014 adjusted EBITDA of $6.775 to $6.975 billion.Expects FY 2014 adjusted earnings per share of $4.82 to $4.94.Q2 2014 EPS of $1.27 - Thomson Reuters I/B/E/S.FY 2014 EBITDA of $6.982 billion and EPS of $4.95 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co's United BioSource Corp partnered with RT Oncology Services Corp
Monday, 31 Mar 2014 08:30am EDT 

Express Scripts Holding Co:United BioSource Corp, subsidiary has been named preferred oncology clinical research partner by RT Oncology Services Corp.Agreement seeks to improve patient care by accelerating clinical research in the U.S.  Full Article

Express Scripts Holding Co announces increase in authorization of share repurchase program - Form 8-K
Wednesday, 5 Mar 2014 04:02pm EST 

Express Scripts Holding Co:Says on March 5, approved an increase in the authorized number of shares that may be repurchased under the company‚Äôs share repurchase program by an additional 65 million shares, or a total authorization of 140 million shares.  Full Article

Express Scripts Holding Co raises FY 2014 earnings guidance-conference call
Monday, 3 Mar 2014 07:50pm EST 

Express Scripts Holding Co:Expects FY 2014 EBITDA growth of 7 pct to 10 pct.Expects FY 2014 EPS growth of 18 pct to 21 pct.Reported EBITDA of $6.664 bln and EPS of $4.30 in FY 2013.FY 2014 EBITDA of $6.967 bln and EPS of $4.94 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co gives FY 2014 EPS outlook; EBITDA outlook below analysts' estimates
Thursday, 20 Feb 2014 04:49pm EST 

Express Scripts Holding Co:Expects FY 2014 adjusted EBITDA of $6.850 to $7.050 bln.Expects FY 2014 Adjusted earnings per share of $4.88 to $5.00.FY 2014 EBITDA of $7.218 bln, EPS of $4.93 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co names Tim Wentworth as President
Tuesday, 28 Jan 2014 04:01pm EST 

Express Scripts Holding Co:Says Tim Wentworth has been appointed as the President of the company.  Full Article

Express Scripts Holding Co names Cathy R. Smith chief financial officer
Tuesday, 14 Jan 2014 08:00am EST 

Express Scripts Holding Co:Says that Cathy R. Smith will join the company as executive vice president and chief financial officer, effective Feb. 10.  Full Article

Berkshire invests in Express Scripts, makes confidential disclosure

- Warren Buffett's Berkshire Hathaway Inc disclosed a new stake in healthcare management company Express Scripts Holding Co and shed its stake in agricultural equipment maker Deere & Co, among several changes in its stock investments during the third quarter.

Search Stocks